BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23909285)

  • 21. Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses.
    Tatematsu M; Seya T; Matsumoto M
    Biochem J; 2014 Mar; 458(2):195-201. PubMed ID: 24524192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin II-induced hypertension and cardiac hypertrophy are differentially mediated by TLR3- and TLR4-dependent pathways.
    Singh MV; Cicha MZ; Nunez S; Meyerholz DK; Chapleau MW; Abboud FM
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1027-H1038. PubMed ID: 30793936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction.
    Sasai M; Shingai M; Funami K; Yoneyama M; Fujita T; Matsumoto M; Seya T
    J Immunol; 2006 Dec; 177(12):8676-83. PubMed ID: 17142768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus NS4B induces the degradation of TRIF to inhibit TLR3-mediated interferon signaling pathway.
    Liang Y; Cao X; Ding Q; Zhao Y; He Z; Zhong J
    PLoS Pathog; 2018 May; 14(5):e1007075. PubMed ID: 29782532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
    Jiang Z; Mak TW; Sen G; Li X
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.
    Gowen BB; Wong MH; Jung KH; Sanders AB; Mitchell WM; Alexopoulou L; Flavell RA; Sidwell RW
    J Immunol; 2007 Apr; 178(8):5200-8. PubMed ID: 17404303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
    Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
    J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA.
    Funami K; Sasai M; Ohba Y; Oshiumi H; Seya T; Matsumoto M
    J Immunol; 2007 Nov; 179(10):6867-72. PubMed ID: 17982077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus.
    Guillot L; Le Goffic R; Bloch S; Escriou N; Akira S; Chignard M; Si-Tahar M
    J Biol Chem; 2005 Feb; 280(7):5571-80. PubMed ID: 15579900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viral double-stranded RNA sensors induce antiviral, pro-inflammatory, and pro-apoptotic responses in human renal tubular epithelial cells.
    Heutinck KM; Rowshani AT; Kassies J; Claessen N; van Donselaar-van der Pant KA; Bemelman FJ; Eldering E; van Lier RA; Florquin S; Ten Berge IJ; Hamann J
    Kidney Int; 2012 Sep; 82(6):664-75. PubMed ID: 22648297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TLR3/TRIF signalling pathway regulates IL-32 and IFN-β secretion through activation of RIP-1 and TRAF in the human cornea.
    Park GB; Hur DY; Kim YS; Lee HK; Yang JW; Kim D
    J Cell Mol Med; 2015 May; 19(5):1042-54. PubMed ID: 25754842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.
    Swiecki M; McCartney SA; Wang Y; Colonna M
    J Leukoc Biol; 2011 Oct; 90(4):691-701. PubMed ID: 21844166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis.
    Harii N; Lewis CJ; Vasko V; McCall K; Benavides-Peralta U; Sun X; Ringel MD; Saji M; Giuliani C; Napolitano G; Goetz DJ; Kohn LD
    Mol Endocrinol; 2005 May; 19(5):1231-50. PubMed ID: 15661832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.
    Lundberg AM; Ketelhuth DF; Johansson ME; Gerdes N; Liu S; Yamamoto M; Akira S; Hansson GK
    Cardiovasc Res; 2013 Jul; 99(2):364-73. PubMed ID: 23417039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-3-3-zeta participates in TLR3-mediated TICAM-1 signal-platform formation.
    Funami K; Matsumoto M; Obuse C; Seya T
    Mol Immunol; 2016 May; 73():60-8. PubMed ID: 27058640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses.
    Yu M; Levine SJ
    Cytokine Growth Factor Rev; 2011 Apr; 22(2):63-72. PubMed ID: 21466970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral signaling through pattern recognition receptors.
    Kawai T; Akira S
    J Biochem; 2007 Feb; 141(2):137-45. PubMed ID: 17190786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
    J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF.
    Xu W; Santini PA; Matthews AJ; Chiu A; Plebani A; He B; Chen K; Cerutti A
    J Immunol; 2008 Jul; 181(1):276-87. PubMed ID: 18566393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.